Invention Grant
- Patent Title: Compositions and methods for inhibiting Wnt signaling
-
Application No.: US16086159Application Date: 2017-03-21
-
Publication No.: US10913786B2Publication Date: 2021-02-09
- Inventor: Min Dong , Liang Tao
- Applicant: Children's Medical Center Corporation
- Applicant Address: US MA Boston
- Assignee: Children's Medical Center Corporation
- Current Assignee: Children's Medical Center Corporation
- Current Assignee Address: US MA Boston
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2017/023381 WO 20170321
- International Announcement: WO2017/165398 WO 20170928
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K14/71 ; C07K14/33 ; A61K47/68 ; A61P35/00 ; C07K16/12 ; C07K16/22 ; C12N15/62 ; C12N15/85 ; A61P31/04 ; A61K31/095 ; A61K31/41
Abstract:
The present disclosure relates to isolated polypeptides that inhibit Wnt signaling, pharmaceutical compositions comprising the isolated polypeptides, and methods of use thereof. Nucleic acids, cells, and methods of production related to the isolated polypeptides and compositions are also disclosed.
Public/Granted literature
- US20190031734A1 COMPOSITIONS AND METHODS FOR INHIBITING WNT SIGNALING Public/Granted day:2019-01-31
Information query
